Global burden of diabetes: new study reveals alarming prevalence and projections for 2050

FHS
July 18, 2023
8:05 am

Comprehensive estimates of diabetes prevalence and burden worldwide.

CStone’s sugemalimab recommended for metastatic NSCLC

CStone has already secured sugemalimab’s approval in China for five cancer indications. Credit: Marko Aliaksandr/Shutterstock.com. The European Medicines Agency’s (EMA) Committee for Medicinal Products for

June 3, 2024

UT Health San Antonio School of Dentistry opens special-care dental clinic in South Texas

The UT Health San Antonio School of Dentistry has opened a special-care dental clinic, the first of its kind in an academic setting in South

February 10, 2024

Cybin Reports Third Quarter Financial Results and Recent Business Highlights | Psychedelic Invest

TORONTO, February 14, 2024–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company“), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new

February 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.